|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Forma Therapeutics Holdings, Inc., (FMTX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
22 |
|
|
|
Total
Direct Shares :
|
2,539,287 |
|
|
Total
Indirect Shares :
|
11,746,941 |
| |
%
Held by Insiders:
|
5.6% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Fanucci Marsha |
Director |
2022-10-14 |
0 |
|
0 |
| Lesser Brian Andrew |
SVP, Commercial Officer |
2022-10-14 |
0 |
|
0 |
| Clackson Timothy P |
Director |
2022-10-14 |
0 |
|
0 |
| Bishop John E |
SVP, Chief Technology Officer |
2022-10-14 |
0 |
2021-06-14 |
0 |
| Potts Jeannette |
See Remarks |
2022-10-14 |
0 |
2020-12-30 |
0 |
| Wiggans Thomas G |
Director |
2022-10-14 |
0 |
2021-06-17 |
0 |
| Shegog Todd |
SVP, Chief Financial Officer |
2022-10-14 |
0 |
2021-02-26 |
0 |
| Melian Agustin |
EVP, Research & Development |
2022-10-14 |
0 |
2022-07-11 |
0 |
| Frederick Wayne A.i. |
Director |
2022-10-14 |
0 |
2021-06-17 |
0 |
| Lee Frank D. |
President and CEO, Director |
2022-10-14 |
0 |
2021-02-26 |
0 |
| Molina Arturo Md |
Director |
2022-10-14 |
0 |
2022-01-12 |
0 |
| Wirth Peter |
Director |
2022-10-14 |
0 |
|
0 |
| Kelly Patrick F. |
SVP, Chief Medical Officer |
2022-04-08 |
104,884 |
|
0 |
| Cook David N |
SVP, Chief Scientific Officer |
2022-02-28 |
41,469 |
2021-02-26 |
0 |
| Wadlinger Mary E. |
See Remarks |
2022-02-23 |
134,521 |
|
0 |
| Kolchinsky Peter |
Director, 10% Owner |
2021-06-17 |
2,750 |
2021-06-17 |
9,011,651 |
| Vickers Selwyn M Md |
Director |
2021-06-17 |
2,750 |
2021-06-17 |
0 |
| Shah Rajeev M. |
10% Owner |
2020-06-23 |
0 |
2022-10-14 |
0 |
| Paoletti Paolo |
Director |
2020-06-23 |
0 |
|
0 |
| Wellington Biomedical Innovation Master Investors |
10% Owner |
2020-06-23 |
2,252,913 |
2020-06-23 |
0 |
| Novartis Ag |
10% Owner |
|
0 |
2020-06-18 |
331,221 |
| Hall Steven Edward |
Director |
|
0 |
2020-06-23 |
2,404,069 |
|
|
